Brian Lian - Apr 13, 2023 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
President & CEO, Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
Apr 13, 2023
Transactions value $
-$1,361,598
Form type
4
Date filed
4/13/2023, 05:14 PM
Previous filing
Apr 3, 2023
Next filing
Apr 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $102K +54.3K +2.33% $1.88* 2.39M Apr 13, 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale -$1.46M -79.3K -3.32% $18.45 2.31M Apr 13, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (right to buy) Options Exercise $0 -54.3K -100% $0.00* 0 Apr 13, 2023 Common Stock 54.3K $1.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person